In this Exclusive Interview, Lora K. Heisler talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about harnessing serotonin in the treatment of obesity and type 2 diabetes.
Diabetes in Control speaks with top endocrinologists and other medical professionals to bring you the latest in diabetes news and research.
Dr. Lora K. Heisler, PhD., is Professor, Chair in Human Nutrition, and Head of the Obesity and Food Choice Division of the Rowett Institute at the University of Aberdeen, Scotland, as well as an elected Fellow of the Royal Society of Edinburgh. Professor Heisler investigates brain circuits regulating energy homeostasis in an effort to identify new targets amenable to obesity and type 2 diabetes medications. Professor Heisler received her PhD from Tufts University, USA in 1997 and held postdoctoral positions at the University of California, San Francisco USA from 1997-99 and Beth Israel Deaconess Medical Center, Harvard Medical School (HMS) USA from 1999-2001. In 2001, Professor Heisler was promoted to Instructor and set up her laboratory at HMS. She then relocated her group to the University of Cambridge, UK in 2004 where they worked until 2013. In 2013, the Heisler group moved to the Rowett Institute to take advantage of the Institute’s strengths in obesity research, ranging from molecules to man.
Pt.1: Treating Diabetes With Serotonin
Pt.2: What Is The Treatment And How Does It Work?
Pt.3: Are There Any New Studies You’re Working On?
Pt.4: What Would You Tell Practitioners About Your Study And Field?